Rune Toftgård
Professor Emeritus
E-postadress: rune.toftgard@ki.se
Telefon: +46852481053
Besöksadress: Blickagången 16, 14152 Flemingsberg
Postadress: H7 Medicin, Huddinge, H7 CeRM Jovine, 171 77 Stockholm
Artiklar
- Article: TRANSGENIC RESEARCH. 2021;30(5):701-707Bergstrom A; Gerling M; Van Hul N; Fernandez Moro C; Rozell B; Toftgard R; Sur I
- Article: INTERNATIONAL JOURNAL OF CANCER. 2020;146(4):1125-1138Norum JH; Frings O; Kasper M; Bergholtz H; Thime HZ; Bergstrom A; Andersson A; Kuiper R; Fredlund E; Sorlie T; Toftgard R
- Article: DEVELOPMENTAL BIOLOGY. 2017;429(1):132-146Hoelzl MA; Heby-Henricson K; Gerling M; Dias JM; Kuiper RV; Trunkle C; Bergstrom A; Ericson J; Toftgard R; Teglund S
- Article: NATURE CELL BIOLOGY. 2016;18(12):1346-1356Blaas L; Pucci F; Messal HA; Andersson AB; Ruiz EJ; Gerling M; Douagi I; Spencer-Dene B; Musch A; Mitter R; Bhaw L; Stone R; Bornhorst D; Sesay AK; Jonkers J; Stamp G; Malanchi I; Toftgard R; Behrens A
- Article: NATURE COMMUNICATIONS. 2016;7:12321Gerling M; Buller NVJA; Kirn LM; Joost S; Frings O; Englert B; Bergstrom A; Kuiper RV; Blaas L; Wielenga MCB; Almer S; Kuhl AA; Fredlund E; van den Brink GR; Toftgard R
- Article: EMBO JOURNAL. 2016;35(13):1400-1416Raducu M; Fung E; Serres S; Infante P; Barberis A; Fischer R; Bristow C; Thezenas M-L; Finta C; Christianson JC; Buffa FM; Kessler BM; Sibson NR; Di Marcotullio L; Toftgard R; D'Angiolella V
- Article: NATURE COMMUNICATIONS. 2016;7:11314Bosma M; Gerling M; Pasto J; Georgiadi A; Graham E; Shilkova O; Iwata Y; Almer S; Soderman J; Toftgard R; Wermeling F; Bostrom EA; Bostrom PA
- Article: METHODS IN MOLECULAR BIOLOGY. 2016;1453:123-136Isolation and Fluorescence-Activated Cell Sorting of Mouse Keratinocytes Expressing β-Galactosidase.Kasper M; Toftgård R; Jaks V
- Article: STEM CELL REPORTS. 2015;5(5):843-855Fullgrabe A; Joost S; Are A; Jacob T; Sivan U; Haegebarth A; Linnarsson S; Simons BD; Clevers H; Toftgard R; Kasper M
- Article: STEM CELLS AND DEVELOPMENT. 2015;24(21):2547-2560Hoelzl MA; Heby-Henricson K; Bilousova G; Rozell B; Kuiper RV; Kasper M; Toftgard R; Teglund S
- Journal article: ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2015;53(08)Gerling M; Kirn L; Büller N; Englert B; Frings O; Fredlund E; Kühl A; Kuiper R; van den Brink G; Toftgård R
- Article: DEVELOPMENTAL BIOLOGY. 2015;404(2):35-48Norum JH; Bergstrom A; Andersson AB; Kuiper RV; Hoelzl MA; Sorlie T; Toftgard R
- Article: MOLECULAR CANCER. 2015;14(1):17Zinke J; Schneider FT; Harter PN; Thom S; Ziegler N; Toftgard R; Plate KH; Liebner S
- Article: CELL REPORTS. 2014;7(3):747-761Goel HL; Gritsko T; Pursell B; Chang C; Shultz LD; Greiner DL; Norum JH; Toftgard R; Shaw LM; Mercurio AM
- Article: ACTA CRYSTALLOGRAPHICA SECTION D: BIOLOGICAL CRYSTALLOGRAPHY. 2013;69(Pt 12):2563-2579Cherry AL; Finta C; Karlstrom M; Jin Q; Schwend T; Astorga-Wells J; Zubarev RA; Del Campo M; Criswell AR; de Sanctis D; Jovine L; Toftgard R
- Journal article: ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE. 2013;140(12):s637Bonnet MC; Kumari S; Ulvmar MH; Wolk K; Karagianni N; Witte E; Uthoff-Hachenberg C; Renauld J-C; Kollias G; Toftgard R; Sabat R; Pasparakis M; Haase I
- Article: IMMUNITY. 2013;39(5):899-911Kumari S; Bonnet MC; Ulvmar MH; Wolk K; Karagianni N; Witte E; Uthoff-Hachenberg C; Renauld J-C; Kollias G; Toftgard R; Sabat R; Pasparakis M; Haase I
- Article: CELL DEATH AND DIFFERENTIATION. 2013;20(8):1080-1088Chari NS; Romano RA; Koster MI; Jaks V; Roop D; Flores ER; Teglund S; Sinha S; Gruber W; Aberger F; Medeiros LJ; Toftgard R; McDonnell TJ
- Journal article: PANCREATOLOGY. 2013;13(3):s19Heuchel R; Gerling M; Zhao Y; Jose J; Norberg J; Toftgård R; Löhr M
- Journal article: CANCER RESEARCH. 2013;73(8_Supplement):1407Norum JH; Andersson A; Kasper M; Sørlie T; Toftgård R
- Visa fler
Alla övriga publikationer
- Editorial: JOURNAL OF INTERNAL MEDICINE. 2021;289(5):601-603Toftgard R
- Corrigendum: NATURE COMMUNICATIONS. 2016;7:12936Gerling M; Buller NVJA; Kirn LM; Joost S; Frings O; Englert B; Bergstrom A; Kuiper RV; Blaas L; Wielenga MCB; Almer S; Kuhl AA; Fredlund E; van den Brink GR; Toftgard R
- Other: CELL DEATH AND DIFFERENTIATION. 2015;22(6):887Toftgard R; Ruiz i Altaba A
- Editorial: DEVELOPMENTAL CELL. 2014;31(1):1-2Lauth M; Toftgard R
- Dataset: PDB. 2013Jovine L; Toftgård R
- Dataset: PDB. 2013Jovine L; Toftgård R
- Dataset: PDB. 2013Jovine L; Toftgård R
- Dataset: PDB. 2013Jovine L; Toftgård R
- Dataset: PDB. 2013Jovine L; Toftgård R
- Editorial: JOURNAL OF INTERNAL MEDICINE. 2013;274(2):102-104Bergh J; Hall P; Ostman A; Toftgard R
- Letter: ACTA ONCOLOGICA. 2013;52(4):862-U221Asklund T; Henriksson R; Axelsson J; Bergstrom A; Kasper M; Ogren M; Toftgard R; Riklund KA
- Meeting abstract: CANCER RESEARCH. 2013;73:b28Roswell P; Haller K; Petersson A; Anderberg C; Li H; Norum J-H; Toftgard R; Eriksson U; Pietras K
- Conference publication: FEBS JOURNAL. 2012;279:26Toftgard R; Finta C; Cherry A; Fullgrabe A; Kasper M; Jovine L
- Corrigendum: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2012;109(14):5548Kasper M; Jaks V; Are A; Bergstrom A; Schwager A; Svard J; Teglund S; Barker N; Toftgard R
- Review: JOURNAL OF CLINICAL INVESTIGATION. 2012;122(2):455-463Kasper M; Jaks V; Hohl D; Toftgard R
- Conference publication: EUROPEAN JOURNAL OF CANCER. 2011;47:S99-S100Norum JH; Kasper M; Jaks V; Toftgard R
- Review: MECHANISMS AND THERAPY OF LIVER CANCER. 2011;110:1-17Lauth M; Toftgard R
- Meeting abstract: EUROPEAN JOURNAL OF CANCER, SUPPLEMENT. 2010;8(5):219Norum JH; Kasper M; Jaks V; Toftgard R
- Visa fler
Forskningsbidrag
- Hedgehog signaling in cancer development and as a target for the development of new cancer drugs.Swedish Cancer Society1 januari 2016Hedgehog signaling is a signaling pathway that is of central importance during the fetal development stage and in tissue regeneration and wound healing in the adult individual. Incorrect reactivation of hedgehog signaling has now proven to be an important contributing factor to several different forms of cancer such as skin cancer and cerebellar cancer. Hedgehog signaling is also of great importance in the control of normal stem cells and cancer-converted stem cells. The project examines basic mechanisms for how incorrect hedgehog signaling contributes to cancer emergence through studies of purified proteins, experimental animal models and patient samples. Of particular interest are hedgehog signaling in skin and breast cancer and cancer of the gastrointestinal tract. The basic knowledge of the signal path is also used to find new therapy strategies and to develop drug candidates. The results from the project will provide new and necessary basic knowledge of how hedgehog signaling goes all the way to three-dimensional structures for components and complexes in the signal path. An important issue that we hope to answer is the importance of hedgehog signaling in the tumor cells themselves versus signaling to surrounding support cells. By continuing studies and further development of the inhibitors of hedgehog signaling we have already identified and seeking new inhibitors, we hope to be able to take further steps in the process of developing new cancer drugs.
- Hedgehog signaling in cancer development and as a target for the development of new cancer drugs.Swedish Cancer Society1 januari 2015Hedgehog signaling is a signaling pathway that is of central importance during the fetal development stage and in tissue regeneration and wound healing in the adult individual. Incorrect reactivation of hedgehog signaling has now proven to be an important contributing factor to several different forms of cancer such as skin cancer and cerebellar cancer. Hedgehog signaling is also of great importance in the control of normal stem cells and cancer-converted stem cells. The project examines basic mechanisms for how incorrect hedgehog signaling contributes to cancer emergence through studies of purified proteins, experimental animal models and patient samples. Of particular interest are hedgehog signaling in skin and breast cancer and cancer of the gastrointestinal tract. The basic knowledge of the signal path is also used to find new therapy strategies and to develop drug candidates. The results from the project will provide new and necessary basic knowledge of how hedgehog signaling goes all the way to three-dimensional structures for components and complexes in the signal path. An important issue that we hope to answer is the importance of hedgehog signaling in the tumor cells themselves versus signaling to surrounding support cells. By continuing studies and further development of the inhibitors of hedgehog signaling we have already identified and seeking new inhibitors, we hope to be able to take further steps in the process of developing new cancer drugs.
- Hedgehog signaling in cancer development and as a target for the development of new cancer drugs.Swedish Cancer Society1 januari 2014Hedgehog signaling is a signaling pathway that is of central importance during the fetal development stage and in tissue regeneration and wound healing in the adult individual. Incorrect reactivation of hedgehog signaling has now proven to be an important contributing factor to several different forms of cancer such as skin cancer and cerebellar cancer. Hedgehog signaling is also of great importance in the control of normal stem cells and cancer-converted stem cells. The project examines basic mechanisms for how incorrect hedgehog signaling contributes to cancer emergence through studies of purified proteins, experimental animal models and patient samples. Of particular interest are hedgehog signaling in skin and breast cancer and cancer of the gastrointestinal tract. The basic knowledge of the signal path is also used to find new therapy strategies and to develop drug candidates. The results from the project will provide new and necessary basic knowledge of how hedgehog signaling goes all the way to three-dimensional structures for components and complexes in the signal path. An important issue that we hope to answer is the importance of hedgehog signaling in the tumor cells themselves versus signaling to surrounding support cells. By continuing studies and further development of the inhibitors of hedgehog signaling we have already identified and seeking new inhibitors, we hope to be able to take further steps in the process of developing new cancer drugs.
- Swedish Research Council1 januari 2013 - 31 december 2016
- Swedish Research Council1 januari 2010 - 31 december 2012
Anställningar
- Professor Emeritus, Medicin, Huddinge, Karolinska Institutet, 2024-2027
- Professor, Medicin, Huddinge, Karolinska Institutet, 2024-2024
- Professor, Biovetenskaper och näringslära, Karolinska Institutet, 2020-2024
- Professor, Senior, Biovetenskaper och näringslära, Karolinska Institutet, 2017-2020
- Professor, Biovetenskaper och näringslära, Karolinska Institutet, 1994-2017
Examina och utbildning
- Docent, Toxikologi, Karolinska Institutet, 1985